SCHEMBL5597503

SCHEMBL5597503

CS(=O)(=O)Nc1cccc(NC(=O)Nc2cc(C3CC3)n[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.45
DHX9 Q08211 1/20 0.44
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KCNJ6 P48051 6/20 0.41
KCNJ3 P48549 6/20 0.41
KCNJ5 P48544 3/20 0.40
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CBLB Q13191 1/20 0.38
TYRO3 Q06418 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
ADRB3 P13945 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597878 0.83 MEN1 (0.53) ALDH1A1SMN1; SMN2POLBHPGDMEN1
SCHEMBL5597514 0.82 TRPV1 (0.44) ALDH1A1KCNJ6KCNJ3KCNJ5MEN1
SCHEMBL5597907 0.82 DDX3X (0.57) ALDH1A1SMN1; SMN2KCNJ6KCNJ3KCNJ5
SCHEMBL5597942 0.82 TP53 (0.47) ALDH1A1SMN1; SMN2KCNJ6KCNJ3KCNJ5
SCHEMBL5597634 0.82 KCNJ6 (0.41) ALDH1A1KCNJ6KCNJ3KCNJ5POLB
SCHEMBL5597681 0.81 TP53 (0.54) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL5597764 0.81 NPC1 (0.53) SMN1; SMN2KCNJ6KCNJ3KCNJ5MEN1
SCHEMBL7050959 0.80 HDAC6 (0.44) KCNJ6KCNJ3KCNJ5MEN1KMT2A
SCHEMBL5597510 0.79 KCNJ6 (0.41) ALDH1A1KCNJ6KCNJ3KCNJ5POLB
SCHEMBL5597880 0.79 RXFP1 (0.44) ALDH1A1KCNJ6KCNJ3KCNJ5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202734-B1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PFIZER ITALIA SRL (IT) 2007-05-02 EP claimed
EP-1202734-A4 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2004-09-01 EP claimed
JP-2003507328-A 2003-02-25 JP claimed
US-6387900-B1 ANTICANCER AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-05-14 US claimed
EP-1202734-A1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-05-08 EP claimed
WO-2001012188-A1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2001-02-22 WO claimed
EP-1202734-B1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PFIZER ITALIA SRL (IT) 2007-05-02 EP disclosed
EP-1202734-A4 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2004-09-01 EP disclosed
US-6387900-B1 ANTICANCER AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-05-14 US disclosed
EP-1202734-A1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-05-08 EP disclosed
WO-2001012188-A1 3(5)-UREIDO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2001-02-22 WO disclosed